Standout Papers
Citation Impact
Citing Papers
The maternal interleukin-17a pathway in mice promotes autism-like phenotypes in offspring
2016 StandoutScience
Topological control of cytokine receptor signaling induces differential effects in hematopoiesis
2019 StandoutScienceNobel
Metabolomics analysis reveals large effects of gut microflora on mammalian blood metabolites
2009 Standout
Position and Direction Tracking of a Magnetic Object Based on an Mx-Atomic Magnetometer
2020
Computational mass spectrometry for small molecules
2013
Navigating freely-available software tools for metabolomics analysis
2017
Key factors influencing ADME properties of therapeutic proteins: A need for ADME characterization in drug discovery and development
2015
[18] Peptidyl dipeptidase A: Angiotensin I-converting enzyme
1995
Independent β-Arrestin2 and Gq/Protein Kinase Cζ Pathways for ERK Stimulated by Angiotensin Type 1A Receptors in Vascular Smooth Muscle Cells Converge on Transactivation of the Epidermal Growth Factor Receptor
2009 StandoutNobel
Potency and selectivity of RXP407 on human, rat, and mouse angiotensin-converting enzyme
2001
The renin–angiotensin system and cancer: old dog, new tricks
2010
New anti-fibrotic mechanisms of n-acetyl-seryl-aspartyl-lysyl-proline in silicon dioxide-induced silicosis
2010
Forces in Tissue Morphogenesis and Patterning
2013 Standout
Fibrosis and hypertensive heart disease
2000
Ultra Performance Liquid Chromatography and High Resolution Mass Spectrometry for the Analysis of Plant Lipids
2011
The Human Intestinal Microbiome in Health and Disease
2016 Standout
Adult Cardiac Stem Cells Are Multipotent and Support Myocardial Regeneration
2003 Standout
Local induction of angiotensin-converting enzyme in the kidney as a mechanism of progressive renal diseases
2003
Erythropoiesis Stimulatory Agent- Resistant Anemia in Dialysis Patients: Review of Causes and Management
2009
MetAlign 3.0: performance enhancement by efficient use of advances in computer hardware
2011
Identification of sulfation sites of metabolites and prediction of the compounds’ biological effects
2006
Role of the N-terminal Catalytic Domain of Angiotensin-converting Enzyme Investigated by Targeted Inactivation in Mice
2004 StandoutNobel
Apoptotic mechanisms in the control of erythropoiesis
2004
Comparative Pharmacology of Newer Progestogens
1996
Development of an Ultrasensitive Noncompetitive Hybridization–Ligation Enzyme-Linked Immunosorbent Assay for the Determination of Phosphorothioate Oligodeoxynucleotide in Plasma
2002
Disruption of oxygen homeostasis underlies congenital Chuvash polycythemia
2002 StandoutNobel
Treatment of infantile-onset spinal muscular atrophy with nusinersen: a phase 2, open-label, dose-escalation study
2016 Standout
Targeting multidrug resistance in cancer
2006 Standout
The critical role of tissue angiotensin-converting enzyme as revealed by gene targeting in mice.
1997 StandoutNobel
Routine renin-angiotensin system blockade in renal transplantation?
2002
Diet–microbiota interactions as moderators of human metabolism
2016 StandoutNature
Drug assay using antibody mimics made by molecular imprinting
1993 StandoutNature
PubChem Substance and Compound databases
2015 Standout
Nanotechnology-based combination therapy for overcoming multidrug-resistant cancer
2017
Vascular injury and modulation of MAPKs: A targeted approach to therapy of restenosis
2007
Current trends and challenges in sample preparation for global metabolomics using liquid chromatography–mass spectrometry
2012
Angiotensin-converting enzyme 2 protects from severe acute lung failure
2005 StandoutNature
Polycystic Ovary Syndrome
2005 Standout
Angiotensin inhibition enhances drug delivery and potentiates chemotherapy by decompressing tumour blood vessels
2013 StandoutNobel
Predicting Network Activity from High Throughput Metabolomics
2013
Antifibrotic effect of Ac-SDKP and angiotensin-converting enzyme inhibition in hypertension
2004
Physiology of Local Renin-Angiotensin Systems
2006 Standout
Substrate Dependence of Angiotensin I-Converting Enzyme Inhibition: Captopril Displays a Partial Selectivity for Inhibition ofN-Acetyl-Seryl-Aspartyl-Lysyl-Proline Hydrolysis Compared with That of Angiotensin I·
1997
Microbiota Modulate Behavioral and Physiological Abnormalities Associated with Neurodevelopmental Disorders
2013 Standout
Angiotensin II Type 1–Receptor Activating Antibodies in Renal-Allograft Rejection
2005 Standout
Molecular basis for polycythemia
1999
Naturally occurring p16Ink4a-positive cells shorten healthy lifespan
2016 StandoutNature
Microfluidic diagnostic technologies for global public health
2006 StandoutNature
A rapid determination of acidic pharmaceuticals in environmental waters by molecularly imprinted solid-phase extraction coupled to tandem mass spectrometry without chromatography
2013
Identification of bioactive metabolites using activity metabolomics
2019
Silicosis
2012 Standout
NOREVA: enhanced normalization and evaluation of time-course and multi-class metabolomic data
2020
Exploring the effects of mechanical feedback on epithelial topology
2010
Remarkable Potential of the α-Aminophosphonate/Phosphinate Structural Motif in Medicinal Chemistry
2011
Computational design of a synthetic PD-1 agonist
2021 StandoutNobel
Photothermal therapy and photoacoustic imaging via nanotheranostics in fighting cancer
2018 Standout
Fibrosis, not cell size, delineates β-myosin heavy chain reexpression during cardiac hypertrophy and normal aging in vivo
2006 StandoutNobel
The metaRbolomics Toolbox in Bioconductor and beyond
2019
Neanderthal ancestry drives evolution of lipid catabolism in contemporary Europeans
2014 StandoutNobel
Reduction of Cardiac Fibrosis Decreases Systolic Performance Without Affecting Diastolic Function in Hypertensive Rats
2004
Selective Angiotensin-Converting Enzyme C-Domain Inhibition Is Sufficient to Prevent Angiotensin I–Induced Vasoconstriction
2004
Development of a Multichannel Microfluidic Analysis System Employing Affinity Capillary Electrophoresis for Immunoassay
2001
Diabetic nephropathy is markedly enhanced in mice lacking the bradykinin B2 receptor
2004 StandoutNobel
Genetically increased angiotensin I-converting enzyme level and renal complications in the diabetic mouse
2001 StandoutNobel
Increased Myocardial Collagen Content in Transgenic Rats Overexpressing Cardiac Angiotensin-Converting Enzyme Is Related to Enhanced Breakdown of N -Acetyl-Ser-Asp-Lys-Pro and Increased Phosphorylation of Smad2/3
2004
Angiotensin-Converting Enzyme C-Terminal Catalytic Domain Is the Main Site of Angiotensin I Cleavage In Vivo
2007 StandoutNobel
Mice Lacking Endothelial ACE
2003 StandoutNobel
Degradable Controlled-Release Polymers and Polymeric Nanoparticles: Mechanisms of Controlling Drug Release
2016 Standout
Decreased renal NO excretion and reduced glomerular tuft area in mice lacking the bradykinin B2receptor
2003
Nanotechnology for Multimodal Synergistic Cancer Therapy
2017 Standout
Prolyl Oligopeptidase Is Involved in Release of the Antifibrotic Peptide Ac-SDKP
2004
Copper-Catalyzed Synthesis of Mixed Alkyl Aryl Phosphonates
2014 StandoutNobel
In Vitro and In Vivo Inhibition of the 2 Active Sites of ACE by Omapatrilat, a Vasopeptidase Inhibitor
2000
New approaches to genetic manipulation of mice: tissue-specific expression of ACE
2003
N-acetyl-seryl-aspartyl-lysyl-proline stimulates angiogenesis in vitro and in vivo
2004
A Decade of Development in Immunoassay Methodology
1990
MetaboAnalyst 4.0: towards more transparent and integrative metabolomics analysis
2018 Standout
N -Acetyl-Ser-Asp-Lys-Pro Inhibits Phosphorylation of Smad2 in Cardiac Fibroblasts
2002
Angiotensin-converting enzyme and male fertility
1998 StandoutNobel
Intense myocyte formation from cardiac stem cells in human cardiac hypertrophy
2003
Levels of Hematopoiesis Inhibitor N -Acetyl-Seryl-Aspartyl-Lysyl-Proline Partially Explain the Occurrence of Anemia in Heart Failure
2005
Structure of P-Glycoprotein Reveals a Molecular Basis for Poly-Specific Drug Binding
2009 StandoutScience
Mice Lacking Endothelial Angiotensin-Converting Enzyme Have a Normal Blood Pressure
2002 StandoutNobel
The ecology of the microbiome: Networks, competition, and stability
2015 StandoutScience
Bradykinin B1 and B2 receptors both have protective roles in renal ischemia/reperfusion injury
2007 StandoutNobel
Impaired urine concentration and absence of tissue ACE: involvement of medullary transport proteins
2002
Roles of the Two Active Sites of Somatic Angiotensin-Converting Enzyme in the Cleavage of Angiotensin I and Bradykinin
2003
Workflow4Metabolomics: a collaborative research infrastructure for computational metabolomics
2014
N-Acetyl-Seryl-Aspartyl-Lysyl-Proline Prevents Renal Insufficiency and Mesangial Matrix Expansion in Diabetic db/db Mice
2005
The tetrapeptide AcSDKP, an inhibitor of primitive hematopoietic cell proliferation, induces angiogenesis in vitro and in vivo
2003
Molecular Origin of Blood‐Based Infrared Spectroscopic Fingerprints**
2021 StandoutNobel
Magnetic‐Field‐Switchable Laser via Optical Pumping of Rubrene
2021 StandoutNobel
Treatment of erythropoietin deficiency in mice with systemically administered siRNA
2012 StandoutNobel
Ac-SDKP Reverses Inflammation and Fibrosis in Rats With Heart Failure After Myocardial Infarction
2003
MetaboAnalyst 5.0: narrowing the gap between raw spectra and functional insights
2021 Standout
Molecular imprinting: perspectives and applications
2016 Standout
Works of Éric Ezan being referenced
Effect of Angiotensin-Converting Enzyme Inhibition on Plasma, Urine, and Tissue Concentrations of Hemoregulatory Peptide Acetyl-Ser-Asp-Lys-Pro in Rats
1999
Mass spectrometry for the identification of the discriminating signals from metabolomics: Current status and future trends
2008
Profiling of sulfoconjugates in urine by using precursor ion and neutral loss scans in tandem mass spectrometry. Application to the investigation of heavy metal toxicity in rats
2004
Pharmacokinetic studies of protein drugs: Past, present and future
2013
A competitive enzyme hybridization assay for plasma determination of phosphodiester and phosphorothioate antisense oligonucleotides
1997
A High-Throughput Screening Microplate Test for the Interaction of Drugs with P-Glycoprotein
2002
Acute angiotensin-converting enzyme inhibition increases the plasma level of the natural stem cell regulator N-acetyl-seryl-aspartyl-lysyl-proline.
1996
Functional consequences of angiotensin-converting enzyme gene polymorphism on N-acetyl-Ser-Asp-Lys-Pro degradation and angiotensin II production
2002
Enzyme immunoassay for nomegestrol acetate in human plasma
1993
Assessment of the metabolism of therapeutic proteins and antibodies
2014
Captopril inhibitsin vitroandin vivothe proliferation of primitive haematopoietic cells induced into cell cycle by cytotoxic drug administration or irradiation but has no effect on myeloid leukaemia cell proliferation
2000
Triton X-100 eliminates plasma proteins interference in a radioimmunoassay for luteinizing hormone-releasing hormone (LHRH) and LHRH analogues
1989
Investigating the plant response to cadmium exposure by proteomic and metabolomic approaches
2011
Lack of angiotensin II–facilitated erythropoiesis causes anemia in angiotensin-converting enzyme–deficient mice
2000 StandoutNobel
Direct analysis of valsartan or candesartan in human plasma and urines by on-line solid phase extraction coupled to electrospray tandem mass spectrometry
2009
Practical method for optimizing radioimmunoassay detection and precision limits
1991
Evaluation of Accurate Mass and Relative Isotopic Abundance Measurements in the LTQ-Orbitrap Mass Spectrometer for Further Metabolomics Database Building
2010
Evaluation of In-Flow Magnetoresistive Chip Cell—Counter as a Diagnostic Tool
2019
In Vivo Assessment of Captopril Selectivity of Angiotensin I-Converting Enzyme Inhibition: Differential Inhibition of Acetyl-Ser-Asp-Lys-Pro and Angiotensin I Hydrolysis
1999
Metabolomic investigation of the response of the model plant Arabidopsis thaliana to cadmium exposure: Evaluation of data pretreatment methods for further statistical analyses
2007
Inhibition of angiotensin I–converting enzyme induces radioprotection by preserving murine hematopoietic short-term reconstituting cells
2004
Lisinopril, an angiotensin I-converting enzyme inhibitor, prevents entry of murine hematopoietic stem cells into the cell cycle after irradiation in vivo.
1998
Liquid Chromatography−Mass Spectrometry and 15N Metabolic Labeling for Quantitative Metabolic Profiling
2005
Renal and Metabolic Clearance ofN-Acetyl-Seryl-Aspartyl-Lysyl-Proline (AcSDKP) During Angiotensin-Converting Enzyme Inhibition in Humans
1999
Pharmcokinetics in healthy volunteers and patients of NAc-SDKP (seraspenide), a negative regulator of hematopoiesis.
1994
RXP 407, a Selective Inhibitor of the N-Domain of Angiotensin I-Converting Enzyme, Blocks in Vivo the Degradation of Hemoregulatory Peptide Acetyl-Ser-Asp-Lys-Pro with No Effect on Angiotensin I Hydrolysis
2001
Effect of chronic ANG I-converting enzyme inhibition on aging processes. I. Kidney structure and function
1994
Annotation of the Human Adult Urinary Metabolome and Metabolite Identification Using Ultra High Performance Liquid Chromatography Coupled to a Linear Quadrupole Ion Trap-Orbitrap Mass Spectrometer
2012
Long-Term Effect ofN-Acetyl-Seryl-Aspartyl-Lysyl-Proline on Left Ventricular Collagen Deposition in Rats With 2-Kidney, 1-Clip Hypertension
2001
Source, catabolism and role of the tetrapeptide N-Acetyl-Ser-Asp-Lys-Pro within the testis
2000
Analysis of the Human Adult Urinary Metabolome Variations with Age, Body Mass Index, and Gender by Implementing a Comprehensive Workflow for Univariate and OPLS Statistical Analyses
2015
High Plasma Level ofN-Acetyl-Seryl-Aspartyl-Lysyl-Proline
1997